JP2006519781A5 - - Google Patents

Download PDF

Info

Publication number
JP2006519781A5
JP2006519781A5 JP2006502449A JP2006502449A JP2006519781A5 JP 2006519781 A5 JP2006519781 A5 JP 2006519781A5 JP 2006502449 A JP2006502449 A JP 2006502449A JP 2006502449 A JP2006502449 A JP 2006502449A JP 2006519781 A5 JP2006519781 A5 JP 2006519781A5
Authority
JP
Japan
Prior art keywords
peptide
nanoparticle according
drug
oligomer
nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006502449A
Other languages
English (en)
Japanese (ja)
Other versions
JP4509999B2 (ja
JP2006519781A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2004/000423 external-priority patent/WO2004071493A1/en
Publication of JP2006519781A publication Critical patent/JP2006519781A/ja
Publication of JP2006519781A5 publication Critical patent/JP2006519781A5/ja
Application granted granted Critical
Publication of JP4509999B2 publication Critical patent/JP4509999B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006502449A 2003-02-17 2004-02-16 医薬送達及び抗原提示システムとしてのペプチドナノ粒子 Expired - Fee Related JP4509999B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03003551 2003-02-17
PCT/IB2004/000423 WO2004071493A1 (en) 2003-02-17 2004-02-16 Peptidic nanoparticles as drug delivery and antigen display systems

Publications (3)

Publication Number Publication Date
JP2006519781A JP2006519781A (ja) 2006-08-31
JP2006519781A5 true JP2006519781A5 (enExample) 2007-03-29
JP4509999B2 JP4509999B2 (ja) 2010-07-21

Family

ID=32864945

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006502449A Expired - Fee Related JP4509999B2 (ja) 2003-02-17 2004-02-16 医薬送達及び抗原提示システムとしてのペプチドナノ粒子

Country Status (6)

Country Link
US (1) US8575110B2 (enExample)
EP (1) EP1594469B1 (enExample)
JP (1) JP4509999B2 (enExample)
AT (1) ATE371437T1 (enExample)
DE (1) DE602004008582T2 (enExample)
WO (1) WO2004071493A1 (enExample)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101675993A (zh) 2003-03-26 2010-03-24 赛托斯生物技术公司 Melan-a肽类似物-病毒样颗粒偶联物
US7226473B2 (en) * 2003-05-23 2007-06-05 Brar Balbir S Treatment of stenotic regions
US20040236414A1 (en) * 2003-05-23 2004-11-25 Brar Balbir S. Devices and methods for treatment of stenotic regions
ES2625905T3 (es) * 2004-10-01 2017-07-20 Midatech Ltd. Nanopartículas que comprenden antígenos y adyuvantes capaces de estimular linfocitos T cooperadores
WO2007001448A2 (en) 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
US20070160628A1 (en) * 2005-08-31 2007-07-12 Birkett Ashley J Stabilized virus-like particles and epitope display systems
AU2006325225B2 (en) 2005-12-14 2013-07-04 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
US9267937B2 (en) 2005-12-15 2016-02-23 Massachusetts Institute Of Technology System for screening particles
US8367113B2 (en) 2006-05-15 2013-02-05 Massachusetts Institute Of Technology Polymers for functional particles
SI2032592T1 (sl) 2006-06-12 2013-10-30 Cytos Biotechnology Ag Postopki za pakiranje oligonukleotidov v virusu-podobne delce RNA bakteriofagov
WO2007150030A2 (en) 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
US9217129B2 (en) 2007-02-09 2015-12-22 Massachusetts Institute Of Technology Oscillating cell culture bioreactor
US10265407B2 (en) 2007-02-15 2019-04-23 Yale University Modular nanodevices for smart adaptable vaccines
WO2008115641A2 (en) * 2007-02-15 2008-09-25 Yale University Modular nanoparticles for adaptable vaccines
US20090074828A1 (en) 2007-04-04 2009-03-19 Massachusetts Institute Of Technology Poly(amino acid) targeting moieties
US20110033522A1 (en) * 2007-09-26 2011-02-10 Dana-Farber Cancer Institute, Inc. Reagents for inducing an immune response
MX2010003642A (es) 2007-10-12 2010-08-09 Massachusetts Inst Technology Nanotecnologia de vacuna.
WO2009109428A2 (en) * 2008-02-01 2009-09-11 Alpha-O Peptides Ag Self-assembling peptide nanoparticles useful as vaccines
SG10201803982TA (en) 2008-05-16 2018-07-30 Taiga Biotechnologies Inc Antibodies and processes for preparing the same
US20120015000A1 (en) * 2008-06-30 2012-01-19 David Lanar Malaria vaccine of self-assembling polypeptide nanoparticles
US8784825B2 (en) 2008-08-28 2014-07-22 Taiga Biotechnologies, Inc. Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC
US8343497B2 (en) 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US8277812B2 (en) 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
JP5557254B2 (ja) 2009-02-10 2014-07-23 国立大学法人 琉球大学 薬物運搬体並びにこれを利用したアジュバントおよびワクチン
AU2010239689A1 (en) * 2009-04-21 2011-11-03 Selecta Biosciences, Inc. Immunonanotherapeutics providing a Th1-biased response
WO2010138193A2 (en) 2009-05-27 2010-12-02 Selecta Biosciences, Inc. Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
CN107617110A (zh) * 2009-08-26 2018-01-23 西莱克塔生物科技公司 诱导t细胞辅助的组合物
CN107029223A (zh) 2010-05-26 2017-08-11 西莱克塔生物科技公司 合成纳米载体联合疫苗
KR20130100290A (ko) 2010-08-30 2013-09-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 협착성 병변을 위한 전단 제어 방출 및 혈전 용해 치료법
CN107320734A (zh) 2011-04-29 2017-11-07 西莱克塔生物科技公司 从合成纳米载体中控制释放免疫抑制剂
JP2014521687A (ja) 2011-07-29 2014-08-28 セレクタ バイオサイエンシーズ インコーポレーテッド 体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア
CA2851917A1 (en) 2011-10-12 2013-04-18 Alpha-O Peptides Ag Self-assembling peptide nanoparticles as vaccines against infection with norovirus
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
CA2907915C (en) 2013-04-03 2023-03-07 Allertein Therapeutics, Llc Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components
CN105307641A (zh) 2013-05-03 2016-02-03 西莱克塔生物科技公司 用于降低不期望体液免疫应答的给药组合
TW201511774A (zh) * 2013-09-18 2015-04-01 Iner Aec Executive Yuan 放射性標誌之主動標靶性醫藥組合物及其用途
US10188136B2 (en) 2016-02-16 2019-01-29 Indian Institute Of Science Education And Research Hydrophobin mimics: process for preparation thereof
US10583156B2 (en) * 2016-12-02 2020-03-10 Taiga Biotechnologies, Inc. Nanoparticle formulations
KR101955928B1 (ko) * 2016-12-30 2019-03-08 경상대학교산학협력단 먹장어 유래 vlrb 단백질의 소수성 테일 도메인을 포함하는 다량체 다가 중합체
EP3585428A1 (en) 2017-02-23 2020-01-01 Alpha-o Peptides AG Self-assembling protein nanoparticles encapsulating immunostimulatory nucleid acids
EP4599848A3 (en) 2017-03-11 2025-12-03 Cartesian Therapeutics, Inc. Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
EP3600402A1 (en) 2017-03-23 2020-02-05 Alpha-O Peptides AG Self-assembling protein nanoparticles with built-in six-helix bundle proteins
US11213582B2 (en) 2018-08-08 2022-01-04 The Regents Of The University Of California Protection against recurrent genital herpes by therapeutic immunization with herpes simplex virus type 2 ribonucleotide reductase protein subunits
EP3952909A4 (en) 2019-04-08 2023-06-07 Taiga Biotechnologies, Inc. COMPOSITIONS AND METHODS FOR CRYOPRESERVING IMMUNE CELLS
SG11202112529WA (en) 2019-05-14 2021-12-30 Taiga Biotechnologies Inc Compositions and methods for treating t cell exhaustion
US12553041B2 (en) 2019-06-04 2026-02-17 Cartesian Therapeutics Inc. Formulations and doses of pegylated uricase
EP4026558A4 (en) * 2019-08-27 2022-10-19 Tokyo Institute of Technology COMPOSITE PROTEIN MONOMER WITH NON-STRUCTURAL VIRUS PROTEIN ON IT, COMPOSITE PROTEIN MONOMER AGGREGATE AND COMBINATIONAL VACCINE WITH AGGREGATE AS THE ACTIVE SUBSTANCE
CN111150841B (zh) * 2019-12-31 2023-08-15 优锐生物医药科技(深圳)有限公司 一种主动免疫调控微粒及其制备方法和应用
CN111150842B (zh) * 2019-12-31 2023-09-05 优锐生物医药科技(深圳)有限公司 一种用于中和胃泌素的主动免疫调控微粒及其制备方法和应用
CN118490818A (zh) * 2020-04-22 2024-08-16 生物技术欧洲股份公司 冠状病毒疫苗
EP4221685A1 (en) 2020-09-29 2023-08-09 Oxford University Innovation Limited Stroke treatment
WO2022106860A1 (en) 2020-11-20 2022-05-27 Pécsi Tudományegyetem Recombinant peptides for use in therapy
EP4444739A2 (en) 2021-12-08 2024-10-16 Oakgrove Bio LLC Biological production of histidine-rich peptides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2581394B1 (fr) * 1985-05-02 1988-08-05 Grp Genie Genetique Particules ayant les proprietes immunogenes de l'antigene hbs et portant un site antigenique etranger aux epitopes portes par l'antigene hbs, vecteurs et cellules animales pour la production de telles particules et compositions contenant de telles particules pour la production de vaccins mixtes
US5041385A (en) * 1986-11-01 1991-08-20 Oxford Gene Systems Limited Vector expressing fusion proteins and particles
US5877279A (en) * 1994-10-13 1999-03-02 Nanoframes, Llc Materials for the production of nanometer structures and use thereof
US6756039B1 (en) * 1999-05-10 2004-06-29 The Regents Of The University Of California Self assembling proteins
EP1191836B1 (en) * 1999-06-25 2004-09-29 Leslie H. Kondejewski Polypeptide compositions formed using a coiled-coil template and methods of use
JP4085231B2 (ja) * 2000-02-28 2008-05-14 株式会社ビークル タンパク質中空ナノ粒子とそれを用いた物質運搬体、ならびに細胞への物質導入方法

Similar Documents

Publication Publication Date Title
JP4509999B2 (ja) 医薬送達及び抗原提示システムとしてのペプチドナノ粒子
JP5312028B2 (ja) インターロイキン−１コンジュゲート及びその使用
JP5302671B2 (ja) ネコアレルゲンコンジュゲートとその使用
Rad-Malekshahi et al. Biomedical applications of self-assembling peptides
JP6088123B2 (ja) ワクチンとして有用な自己会合ペプチドナノ粒子
US10378018B2 (en) RNA-based compositions and adjuvants for prophylactic and therapeutic treatment
ES2317711T3 (es) Presentacion molecular de alergenos, metodos de preparacion y uso.
JP2010524849A5 (enExample)
Hersh et al. Peptide-modified biopolymers for biomedical applications
JP2022553826A5 (enExample)
JP2008523132A (ja) Ｉｌ−１５抗原アレイとその使用法
JP2002513805A5 (enExample)
JP2008521426A5 (enExample)
CN106008716A (zh) 呼吸道合胞病毒抗原组合物和方法
Hashemzadeh et al. Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus
CN1972710B (zh) 包含噬菌体纳米颗粒的方法和组合物
Crooke et al. Immunological properties of protein–polymer nanoparticles
Wu et al. Virus-like particles armored by an endoskeleton
Distaffen et al. Multivalent display of chemical signals on self‐assembled peptide scaffolds
Aldaais A comprehensive review on the COVID-19 vaccine and drug delivery applications of interpenetrating polymer networks
EP3487527A1 (en) Plant virus or virus-like particle constructs
Yao et al. Bioinspired IgM‐Mimetic Polyvalent Aptamer‐Albumin Nanoplatform for Targeted Intravesical Therapy of Bladder Cancer
JPWO2014080983A1 (ja) 糖鎖修飾三量体構造オリゴヌクレオチド及びその使用
US12433840B2 (en) Melt processed viral nanoparticle constructs
KR102184153B1 (ko) 고분자 지지체 기반의 인플루엔자 바이러스 유사 구조체 및 이의 제조방법